OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma
Su Yin Lim, Elena Shklovskaya, Jenny Lee, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 59
Su Yin Lim, Elena Shklovskaya, Jenny Lee, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 59
Showing 26-50 of 59 citing articles:
The Role of T-Cadherin (CDH13) in Treatment Options with Garcinol in Melanoma
Sebastian Staebler, Sebastian Hoechst, Aranya Thongmao, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1853-1853
Open Access | Times Cited: 3
Sebastian Staebler, Sebastian Hoechst, Aranya Thongmao, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1853-1853
Open Access | Times Cited: 3
Local CpG-Stat3 siRNA treatment improves antitumor effects of immune checkpoint inhibitors
Chunyan Zhang, Rui Huang, Lyuzhi Ren, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 4, pp. 102357-102357
Closed Access | Times Cited: 3
Chunyan Zhang, Rui Huang, Lyuzhi Ren, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 4, pp. 102357-102357
Closed Access | Times Cited: 3
A Smart DNA Hydrogel Enables Synergistic Immunotherapy and Photodynamic Therapy of Melanoma
Sen Yang, Junlin Wu, Zhongyu Wang, et al.
Angewandte Chemie (2024) Vol. 136, Iss. 14
Closed Access | Times Cited: 2
Sen Yang, Junlin Wu, Zhongyu Wang, et al.
Angewandte Chemie (2024) Vol. 136, Iss. 14
Closed Access | Times Cited: 2
Targeted DNA Sequencing of Cutaneous Melanoma Identifies Prognostic and Predictive Alterations
Alexandra M. Haugh, Robert C. Osorio, R François, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1347-1347
Open Access | Times Cited: 2
Alexandra M. Haugh, Robert C. Osorio, R François, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1347-1347
Open Access | Times Cited: 2
Lymphatic system regulation of anti-cancer immunity and metastasis
Pin‐Ji Lei, Cameron Fraser, Dennis Jones, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Pin‐Ji Lei, Cameron Fraser, Dennis Jones, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Melanoma genomics – will we go beyond BRAF in clinics?
Justyna Mirek, Wiesław Bal, Magdalena Olbryt
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 9
Open Access | Times Cited: 2
Justyna Mirek, Wiesław Bal, Magdalena Olbryt
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 9
Open Access | Times Cited: 2
Analysis of the response of AXL and/or MITF melanoma subpopulations to immunotherapy
Marcella Willemsen, Jenny Bulgarelli, Sudhir Kumar Chauhan, et al.
Immuno-Oncology Technology (2024) Vol. 24, pp. 101009-101009
Open Access | Times Cited: 2
Marcella Willemsen, Jenny Bulgarelli, Sudhir Kumar Chauhan, et al.
Immuno-Oncology Technology (2024) Vol. 24, pp. 101009-101009
Open Access | Times Cited: 2
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma
Lidia Giraudo, Giulia Cattaneo, Loretta Gammaitoni, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 5
Lidia Giraudo, Giulia Cattaneo, Loretta Gammaitoni, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 5
Strategies to overcome low MHC-I expression in paediatric and adult tumours
Joël Guillaume, Alicia Perzolli, Marianne Boes
Immunotherapy Advances (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 5
Joël Guillaume, Alicia Perzolli, Marianne Boes
Immunotherapy Advances (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 5
Resistance to Immune Checkpoint Blockade: IFNγ or MHC-I?
Alexandra Haugh, Adil Daud
Cancer Immunology Research (2023) Vol. 11, Iss. 7, pp. 864-864
Closed Access | Times Cited: 4
Alexandra Haugh, Adil Daud
Cancer Immunology Research (2023) Vol. 11, Iss. 7, pp. 864-864
Closed Access | Times Cited: 4
Development and Validation of a Novel Prognosis Model Based on a Panel of Three Immunogenic Cell Death-Related Genes for Non-Cirrhotic Hepatocellular Carcinoma
Jiaojiao Gong, Renjie Yu, Xiaoxia Hu, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 1609-1628
Open Access | Times Cited: 4
Jiaojiao Gong, Renjie Yu, Xiaoxia Hu, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 1609-1628
Open Access | Times Cited: 4
Refining mutanome-based individualised immunotherapy of melanoma using artificial intelligence
Farida Zakariya, Fatma K. Salem, Abdulwhhab Abu Alamrain, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1
Farida Zakariya, Fatma K. Salem, Abdulwhhab Abu Alamrain, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1
Prognostic and immune infiltration implications of SIGLEC9 in SKCM
Yang Peipei, Yunhui Jiang, Rong Chen, et al.
Diagnostic Pathology (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Yang Peipei, Yunhui Jiang, Rong Chen, et al.
Diagnostic Pathology (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Chitosan/dextran-based organohydrogel delivers EZH2 inhibitor to epigenetically reprogram chemo/immuno-resistance in unresectable metastatic melanoma
Qi Tang, Shaolong Leng, Yinqiu Tan, et al.
Carbohydrate Polymers (2024) Vol. 346, pp. 122645-122645
Closed Access | Times Cited: 1
Qi Tang, Shaolong Leng, Yinqiu Tan, et al.
Carbohydrate Polymers (2024) Vol. 346, pp. 122645-122645
Closed Access | Times Cited: 1
Single-cell RNA sequencing reveals melanoma cell state-dependent heterogeneity of response to MAPK inhibitors
Su Yin Lim, Yingxin Lin, Jenny Lee, et al.
EBioMedicine (2024) Vol. 107, pp. 105308-105308
Open Access | Times Cited: 1
Su Yin Lim, Yingxin Lin, Jenny Lee, et al.
EBioMedicine (2024) Vol. 107, pp. 105308-105308
Open Access | Times Cited: 1
CSF1R Ligands Expressed by Murine Gliomas Promote M-MDSCs to Suppress CD8+ T Cells in a NOS-Dependent Manner
Gregory P. Takacs, Julia S. Garcia, Caitlyn A. Hodges, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 3055-3055
Open Access | Times Cited: 1
Gregory P. Takacs, Julia S. Garcia, Caitlyn A. Hodges, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 3055-3055
Open Access | Times Cited: 1
Immune Checkpoint Inhibitor Therapy for Metastatic Melanoma: What Should We Focus on to Improve the Clinical Outcomes?
Sultana Mehbuba Hossain, Kevin Ly, Yih Jian Sung, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10120-10120
Open Access | Times Cited: 1
Sultana Mehbuba Hossain, Kevin Ly, Yih Jian Sung, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10120-10120
Open Access | Times Cited: 1
Extracellular vesicles powered cancer immunotherapy: Targeted delivery of adenovirus-based cancer vaccine in humanized melanoma model
Sara Mathlouthi, Łukasz Kuryk, Marta Prygiel, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 777-793
Open Access | Times Cited: 1
Sara Mathlouthi, Łukasz Kuryk, Marta Prygiel, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 777-793
Open Access | Times Cited: 1
Overcoming Resistance Mechanisms to Melanoma Immunotherapy
David X. Zheng, David J. Bozym, Giuseppe Tarantino, et al.
American Journal of Clinical Dermatology (2024)
Closed Access | Times Cited: 1
David X. Zheng, David J. Bozym, Giuseppe Tarantino, et al.
American Journal of Clinical Dermatology (2024)
Closed Access | Times Cited: 1
Targeted DNA Sequencing of Cutaneous Melanoma Identifies Prognostic and Predictive Alterations
Alexandra M. Haugh, Robert C. Osorio, R François, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Alexandra M. Haugh, Robert C. Osorio, R François, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Glioma-derived M-CSF and IL-34 license M-MDSCs to suppress CD8+T cells in a NOS-dependent manner
Gregory P. Takacs, Julia S. Garcia, Caitlyn A. Hodges, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Gregory P. Takacs, Julia S. Garcia, Caitlyn A. Hodges, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
MiR-204-5p overexpression abrogates Dacarbazine-induced senescence in melanoma cells in vivo MiR-204-5p abrogates senescence
Ekaterina Lapkina, Ivan Zinchenko, Viktoriya Kutcenko, et al.
Non-coding RNA Research (2024) Vol. 10, pp. 130-139
Open Access
Ekaterina Lapkina, Ivan Zinchenko, Viktoriya Kutcenko, et al.
Non-coding RNA Research (2024) Vol. 10, pp. 130-139
Open Access
Histone Deacetylases
Shunsheng Zheng, Wojciech Barczak, Geng Liu, et al.
Royal Society of Chemistry eBooks (2024), pp. 228-265
Closed Access
Shunsheng Zheng, Wojciech Barczak, Geng Liu, et al.
Royal Society of Chemistry eBooks (2024), pp. 228-265
Closed Access
A co-culture model to study modulators of tumor immune evasion through scalable arrayed CRISPR-interference screens
Ramiro Martinez, C. Finocchiaro, Louis Delhaye, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Ramiro Martinez, C. Finocchiaro, Louis Delhaye, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Insights for the immunotherapy in malignant melanoma: a new revolution
Jiangying Xuan, Zixu Gao, Chuanyuan Wei, et al.
Clinical Cancer Bulletin (2024) Vol. 3, Iss. 1
Open Access
Jiangying Xuan, Zixu Gao, Chuanyuan Wei, et al.
Clinical Cancer Bulletin (2024) Vol. 3, Iss. 1
Open Access
